Alembic Pharmaceuticals informs about disclosure
Alembic Pharmaceuticals has informed that Alembic Pharmaceuticals Inc., wholly owned subsidiary of the Company has acquired Utility Therapeutics. The disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding the aforesaid acquisition is enclosed as Annexure – I.
The above information is a part of company’s filings submitted to BSE.
